List of Tables
Table 1. Global Ipilimumab Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Ipilimumab Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Ipilimumab Market Competitive Situation by Manufacturers in 2024
Table 4. Global Ipilimumab Sales (KG) of Key Manufacturers (2020-2025)
Table 5. Global Ipilimumab Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Ipilimumab Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Ipilimumab Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Ipilimumab Average Price (US$/G) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Ipilimumab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ipilimumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ipilimumab, Product Type & Application
Table 12. Global Key Manufacturers of Ipilimumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ipilimumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ipilimumab as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ipilimumab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Ipilimumab Sales by Region (2020-2025) & (KG)
Table 18. Global Ipilimumab Sales Market Share by Region (2020-2025)
Table 19. Global Ipilimumab Sales by Region (2026-2031) & (KG)
Table 20. Global Ipilimumab Sales Market Share by Region (2026-2031)
Table 21. Global Ipilimumab Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Ipilimumab Revenue Market Share by Region (2020-2025)
Table 23. Global Ipilimumab Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Ipilimumab Revenue Market Share by Region (2026-2031)
Table 25. North America Ipilimumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Ipilimumab Sales by Country (2020-2025) & (KG)
Table 27. North America Ipilimumab Sales by Country (2026-2031) & (KG)
Table 28. North America Ipilimumab Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Ipilimumab Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Ipilimumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Ipilimumab Sales by Country (2020-2025) & (KG)
Table 32. Europe Ipilimumab Sales by Country (2026-2031) & (KG)
Table 33. Europe Ipilimumab Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Ipilimumab Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Ipilimumab Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Ipilimumab Sales by Region (2020-2025) & (KG)
Table 37. Asia Pacific Ipilimumab Sales by Region (2026-2031) & (KG)
Table 38. Asia Pacific Ipilimumab Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Ipilimumab Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Ipilimumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Ipilimumab Sales by Country (2020-2025) & (KG)
Table 42. Latin America Ipilimumab Sales by Country (2026-2031) & (KG)
Table 43. Latin America Ipilimumab Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Ipilimumab Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Ipilimumab Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Ipilimumab Sales by Country (2020-2025) & (KG)
Table 47. Middle East and Africa Ipilimumab Sales by Country (2026-2031) & (KG)
Table 48. Middle East and Africa Ipilimumab Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Ipilimumab Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Ipilimumab Sales (KG) by Type (2020-2025)
Table 51. Global Ipilimumab Sales (KG) by Type (2026-2031)
Table 52. Global Ipilimumab Sales Market Share by Type (2020-2025)
Table 53. Global Ipilimumab Sales Market Share by Type (2026-2031)
Table 54. Global Ipilimumab Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Ipilimumab Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Ipilimumab Revenue Market Share by Type (2020-2025)
Table 57. Global Ipilimumab Revenue Market Share by Type (2026-2031)
Table 58. Global Ipilimumab Price (US$/G) by Type (2020-2025)
Table 59. Global Ipilimumab Price (US$/G) by Type (2026-2031)
Table 60. Global Ipilimumab Sales (KG) by Application (2020-2025)
Table 61. Global Ipilimumab Sales (KG) by Application (2026-2031)
Table 62. Global Ipilimumab Sales Market Share by Application (2020-2025)
Table 63. Global Ipilimumab Sales Market Share by Application (2026-2031)
Table 64. Global Ipilimumab Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Ipilimumab Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Ipilimumab Revenue Market Share by Application (2020-2025)
Table 67. Global Ipilimumab Revenue Market Share by Application (2026-2031)
Table 68. Global Ipilimumab Price (US$/G) by Application (2020-2025)
Table 69. Global Ipilimumab Price (US$/G) by Application (2026-2031)
Table 70. Gilead Company Information
Table 71. Gilead Description and Business Overview
Table 72. Gilead Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
Table 73. Gilead Ipilimumab Product
Table 74. Gilead Recent Developments/Updates
Table 75. BMS Company Information
Table 76. BMS Description and Business Overview
Table 77. BMS Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
Table 78. BMS Ipilimumab Product
Table 79. BMS Recent Developments/Updates
Table 80. Ono Company Information
Table 81. Ono Description and Business Overview
Table 82. Ono Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
Table 83. Ono Ipilimumab Product
Table 84. Ono Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
Table 88. Roche Ipilimumab Product
Table 89. Roche Recent Developments/Updates
Table 90. Prestige BioPharma Company Information
Table 91. Prestige BioPharma Description and Business Overview
Table 92. Prestige BioPharma Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
Table 93. Prestige BioPharma Ipilimumab Product
Table 94. Prestige BioPharma Recent Developments/Updates
Table 95. Avacta Company Information
Table 96. Avacta Description and Business Overview
Table 97. Avacta Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
Table 98. Avacta Ipilimumab Product
Table 99. Avacta Recent Developments/Updates
Table 100. Baxter Company Information
Table 101. Baxter Description and Business Overview
Table 102. Baxter Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
Table 103. Baxter Ipilimumab Product
Table 104. Baxter Recent Developments/Updates
Table 105. Shenyang Sansheng Pharmaceutical Company Information
Table 106. Shenyang Sansheng Pharmaceutical Description and Business Overview
Table 107. Shenyang Sansheng Pharmaceutical Ipilimumab Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2020-2025)
Table 108. Shenyang Sansheng Pharmaceutical Ipilimumab Product
Table 109. Shenyang Sansheng Pharmaceutical Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Ipilimumab Distributors List
Table 113. Ipilimumab Customers List
Table 114. Ipilimumab Market Trends
Table 115. Ipilimumab Market Drivers
Table 116. Ipilimumab Market Challenges
Table 117. Ipilimumab Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Ipilimumab
Figure 2. Global Ipilimumab Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Ipilimumab Market Share by Type: 2024 & 2031
Figure 4. PD - L1 Antagonists Product Picture
Figure 5. CTLA4 Antagonists Product Picture
Figure 6. Immunocheckpoint Inhibitors Product Picture
Figure 7. Other Product Picture
Figure 8. Global Ipilimumab Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Ipilimumab Market Share by Application: 2024 & 2031
Figure 10. Cancer
Figure 11. Melanoma
Figure 12. Global Ipilimumab Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Ipilimumab Market Size (2020-2031) & (US$ Million)
Figure 14. Global Ipilimumab Sales (2020-2031) & (KG)
Figure 15. Global Ipilimumab Average Price (US$/G) & (2020-2031)
Figure 16. Ipilimumab Report Years Considered
Figure 17. Ipilimumab Sales Share by Manufacturers in 2024
Figure 18. Global Ipilimumab Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Ipilimumab Players: Market Share by Revenue in Ipilimumab in 2024
Figure 20. Ipilimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Ipilimumab Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Ipilimumab Sales Market Share by Country (2020-2031)
Figure 23. North America Ipilimumab Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Ipilimumab Sales Market Share by Country (2020-2031)
Figure 27. Europe Ipilimumab Revenue Market Share by Country (2020-2031)
Figure 28. Germany Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Ipilimumab Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Ipilimumab Revenue Market Share by Region (2020-2031)
Figure 35. China Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Ipilimumab Sales Market Share by Country (2020-2031)
Figure 46. Latin America Ipilimumab Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Ipilimumab Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Ipilimumab Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Ipilimumab Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Ipilimumab by Type (2020-2031)
Figure 56. Global Revenue Market Share of Ipilimumab by Type (2020-2031)
Figure 57. Global Ipilimumab Price (US$/G) by Type (2020-2031)
Figure 58. Global Sales Market Share of Ipilimumab by Application (2020-2031)
Figure 59. Global Revenue Market Share of Ipilimumab by Application (2020-2031)
Figure 60. Global Ipilimumab Price (US$/G) by Application (2020-2031)
Figure 61. Ipilimumab Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
